CompuGroup Medical Strengthens its Market Position in the Netherlands

CompuGroup MedicalCompuGroup Medical concluded an agreement to acquire 100% of the shares in Microbais Werkmaatschappij B.V.. Microbais is one of the market leaders in ambulatory and pharmacy information systems in the Netherlands. The 2011 turnover is expected to amount to 11.2 million Euro with about 70% recurring revenue and EBITDA is expected to be 2.5 million Euro.

Microbais employs around 90 employees and is headquartered in Amsterdam. Around 475 pharmacies as well as 150 doctors' practices count among the company's customers. This is equivalent to a market share of about 25% within pharmacies and 4% within office-based physicians.

With this acquisition CompuGroup Medical increases its market shares in the Dutch pharmacy and doctor software markets to around 45% and 15% respectively. Customers will be provided with access to the international product platform of CompuGroup Medical and benefit from SAM solutions (intelligent software assisted medicine) that are worldwide leading in terms of innovation and security.

In this transaction CompuGroup Medical also acquires a 51% majority holding in MediPharma Online, a start-up enterprise in the field of networking between patients and pharmacies.

Frank Gotthardt, CEO of CompuGroup Medical AG, underlined the relevance of this acquisition: "After the successful acquisition of Ascon Euroned, today CGM Netherlands, the purchase of Microbais is a crucial step towards extending the market position in the Dutch pharmacy software sector. At the same time we strengthen our coverage in the field of ambulatory information systems. The highly positive feedback from shareholders and employees of Microbais regarding this transaction encourages us in using this excellent start into the year 2012 with full power in the best interest of our customers."

The purchase price amounts to approximately 15,0 million Euro and will be financed from existing cash and credit facilities.

Related news articles:

About CompuGroup Medical AG
CompuGroup Medical is one of the leading eHealth companies in the world. Its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of over 385,000 doctors, dentists, hospitals, pharmacies and networks as well as other service providers. With locations in 19 countries and customers in 33 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 3,600 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...